FluMist Comparison To Inactivated Vaccine Suggested By FDA Committee

MedImmune should conduct head-to-head comparisons of its live intranasal flu vaccine FluMist and the marketed trivalent inactivated vaccine, FDA's Vaccine & Related Biological Drug Products Advisory Committee suggested Dec. 17

More from Archive

More from Pink Sheet